Related Experiment Video
Updated: Jan 27, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and
Constantinos Simillis1,2, Eliana Kalakouti3, Thalia Afxentiou4
1Department of Colorectal Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, Twickenham Road, Isleworth, London, TW7 6AF, UK. csimillis@gmail.com.
Primary tumor resection (PTR) in incurable colorectal cancer improves survival, including overall, cancer-specific, and progression-free survival. This approach offers a survival benefit without a significant increase in patient morbidity.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Colorectal cancer (CRC) poses a significant global health challenge.
- Management of incurable CRC requires careful consideration of treatment strategies.
- The role of primary tumor resection (PTR) in incurable CRC remains a subject of investigation.
Purpose of the Study:
- To evaluate the impact of primary tumor resection (PTR) on survival outcomes in patients with incurable colorectal cancer.
- To assess the associated morbidity and mortality rates following PTR.
- To compare PTR with non-resectional approaches for primary tumor management in this patient population.
Main Methods:
- A systematic literature review and meta-analysis were conducted.
- Studies comparing PTR versus primary tumor intact (PTI) were included.
- Seventy-seven studies encompassing 159,991 participants were analyzed.
Main Results:
- PTR significantly improved overall survival (HR 0.59), cancer-specific survival (HR 0.47), and progression-free survival (HR 0.76).
- Survival benefits were observed across various subgroups, including asymptomatic and elderly patients.
- PTR demonstrated a perioperative mortality of 4.5% and morbidity of 22.4%, compared to 21.7% for PTI and 21.7% for non-resectional surgery (NRS).
Conclusions:
- Primary tumor resection offers a limited survival improvement in incurable colorectal cancer without a significant increase in morbidity.
- The decision for PTR should be individualized and made by a multidisciplinary team.
- Further research may refine patient selection for PTR in advanced colorectal cancer.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Directing Effect of Substituents: meta-Directing Groups
Cancer Survival Analysis

